ClinicalTrials.gov · Clinical Trial Update · 2026-07-21
PreliminaryPhase 3 trial of a novel siderophore cephalosporin for carbapenem-resistant infections completes enrollment
Why it matters. A potential future option for infections you help manage; a catalyst to watch.
Study design
- Design
- Phase 3 RCT (ongoing)
- Population
- Adults with CRE/CRAB infections
- Setting
- International
- Sample size
- n = 430
Provenance
- Source
- ClinicalTrials.gov
- Source type
- trial_registry
- Content analyzed
- metadata only
Evidence grading reflects the portion of the source actually analyzed. Always confirm against the original before acting.
Your read
Post your interpretation for colleagues. Every post stays anchored to this source, no empty-box updates.
Sign in to post your read of this evidence.